Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries
New England Journal of Medicine · 13.08.2026 · 395 (7) · 684-693
DOI: 10.1056/nejmra2507061 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 13.08.2026. Verfasst von Donna Shelley und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Global Public Health, New York University, New York. Hauptthemen laut MEDLINE: Developing Countries, Health Services Accessibility, Smoking Cessation, Tobacco Use Cessation. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Tobacco use is the leading cause of preventable death globally, claiming more than 7 million lives each year. The burden of disease is highest in low- and middle-income countries, where more than 80% of the world's 1.3 billion tobacco users reside. The World Health Organization (WHO) defines six proven strategies to reduce tobacco use, referred to by the acronym MPOWER, with one of the strategies being to offer tobacco users help with quitting. Many low- and middle-income countries provide tobacco-cessation services; however, only 31 meet the WHO best practice, defined as providing both cost-covered behavioral interventions and pharmacotherapy. In this article, case studies from India and Vietnam illustrate how cross-country differences in tobacco-related sociocultural norms, tobacco-use patterns (e.g., smokeless tobacco or water pipes), the tobacco-control regulatory environment, industry influence, and health care system financing shape treatment access and uptake. These cases further show that cost-effective population-level strategies, including quitlines, digital interventions, and systemwide screening for tobacco use paired with clinician advice to quit, are essential for expanding treatment reach. Combining these interventions with pharmacotherapy products that are included on the WHO Model List of Essential Medicines (e.g., cytisine and nicotine-replacement therapy) further improves cessation outcomes. System-level models, such as the Ask-Advise-Connect model (ask about tobacco use, advise to quit, connect to cessation help), offer a feasible, low-burden pathway for integrating cessation care into routine practice. Ultimately, curbing the rising global burden of tobacco-related disease requires establishing comprehensive cessation support as a universal standard of care, which would ensure equitable access for those most affected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Global Public Health, New York University, New York.
- Tobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston.
- National Institute of Mental Health and Neurosciences, Bangalore, India.
- Center for Population Health Sciences, Hanoi University of Public Health, Hanoi.
- Hull York Medical School, University of York, York, United Kingdom.
ORCID-Profile: Donna Shelley, Nancy A Rigotti
Zitieren
APA
Shelley, D., Rigotti, N. A., Murthy, P., Van Minh, H., & Siddiqi, K. (2026). Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries. New England Journal of Medicine, 395(7), 684-693. https://doi.org/10.1056/nejmra2507061
Vancouver
Shelley D, Rigotti NA, Murthy P, Van Minh H, Siddiqi K. Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries. New England Journal of Medicine. 2026;395(7):684-693. doi:10.1056/nejmra2507061
BibTeX
@article{Shelley2026,
author = {Shelley, Donna and Rigotti, Nancy A and Murthy, Pratima and Van Minh, Hoang and Siddiqi, Kamran},
title = {Evidence-Based Tobacco-Cessation Strategies for Low- and Middle-Income Countries},
journal = {New England Journal of Medicine},
year = {2026},
volume = {395},
number = {7},
pages = {684--693},
doi = {10.1056/nejmra2507061}
}
EUVIMED